Stem Cell for Kidney Failure in Mexico

The estimated cost of stem cell therapy for kidney failure in Mexico City typically ranges from $5,000 to $15,000. Prices vary based on the type of stem cells used, the number of required sessions, and the specific clinic protocols. Navigating the options for chronic kidney disease management often leads patients to research alternative and investigational treatments. A growing number of individuals are exploring stem cell therapy for kidney failure in Mexico City as a potential adjunct therapy. While traditional treatments like dialysis and kidney transplantation remain the standard of care, regenerative medicine is being studied for its potential to modulate inflammation and support remaining kidney function. If you are considering this path, understanding the financial investment, the medical realities, and the logistics of traveling abroad is essential. This guide explores the costs, procedures, and considerations for patients researching this investigational treatment in Mexico's capital. Key Takeaways Estimated procedural costs range between $5,000 and $15,000, depending on individual treatment plans. Stem cell therapy for kidney disease is currently an investigational treatment, not a confirmed cure. It does not replace standard medical care, such as dialysis or kidney transplants. Treatments usually utilize mesenchymal stem cells (MSCs) sourced from bone marrow, fat, or umbilical cord tissue. Consulting with your primary nephrologist before traveling abroad for experimental therapies is strongly advised. How Does Stem Cell Therapy for Kidney Disease Work? Stem cell therapy aims to use the body's natural regenerative mechanisms to potentially reduce renal inflammation and support the health of surviving kidney tissue. In medical research, mesenchymal stem cells (MSCs) are often studied for their immunomodulatory properties. When introduced into the body, researchers believe these cells may help regulate the immune system, potentially decreasing the chronic inflammation that often accelerates kidney damage in patients with chronic kidney disease (CKD). Furthermore, early studies suggest that stem cells may secrete growth factors and proteins that support blood vessel health and promote cellular repair. However, it is crucial to understand that these cells do not spontaneously turn into new, fully functioning kidneys. The therapy is focused on preserving existing function rather than reversing end-stage renal disease. Because this field is still emerging, results vary widely from person to person. What Factors Affect the Stem Cell Therapy for Kidney Failure Cost in Mexico City? The final price depends on the source of the stem cells, the required cell dosage, the number of treatment sessions, and any additional supportive medical therapies provided. When analyzing the stem cell therapy for kidney failure cost in Mexico City, patients will find that no two treatment plans are priced exactly the same. The primary driver of cost is the cell source. Autologous treatments—where cells are harvested from your own fat tissue or bone marrow, processed in a lab, and re-administered—tend to have different costs compared to allogeneic treatments, which use carefully screened donor cells, typically from umbilical cord tissue. Additionally, the severity of your condition dictates the dosage (often measured in millions of cells) and the frequency of administration. Some patients may require a single intensive session, while others might be advised to undergo multiple sessions over a few weeks or months. Clinic amenities, the expertise of the medical team, and the inclusion of supportive therapies like IV vitamins or specialized nutrition plans also influence the overall bill. What Types of Stem Cells Are Typically Used? Facilities usually utilize either autologous (your own) or allogeneic (donor) mesenchymal stem cells derived from bone marrow, adipose (fat) tissue, or umbilical cord tissue. Mesenchymal stem cells (MSCs) are the most common type used in these regenerative protocols because they are relatively easy to harvest and have shown potential in modulating immune responses. If a clinic uses autologous cells, the process involves a minor surgical procedure to extract fat or bone marrow. The advantage here is zero risk of immune rejection since the cells are your own. However, the quality of a patient's own stem cells may be diminished by age or chronic illness. Alternatively, many international clinics prefer allogeneic umbilical cord-derived MSCs. These cells are considered "younger" and highly robust. Because they are immunologically immature, they rarely provoke an immune response in the recipient, even without matching blood types. Reputable facilities follow strict screening protocols to ensure donor cells are free from genetic anomalies and infectious diseases. Expert Insight Regardless of the cell type used, patients must ensure the clinic has transparent, documented laboratory processes for processing and culturing cells safely to avoid contamination. Can This Therapy Replace Dialysis or a Kidney Transplant? No, stem cell therapy is currently an investigational approach and is not a proven medical replacement for life-sustaining treatments like dialysis or a kidney transplant. Managing expectations is one of the most critical parts of exploring regenerative medicine. Stem cell treatments do not cure end-stage renal disease (ESRD). If your kidneys have failed and you require dialysis to filter waste from your blood, stem cell therapy will not suddenly eliminate that need. The destruction of nephrons (the filtering units of the kidney) is largely irreversible once severe scarring has occurred. Patients who report the most benefit from experimental stem cell protocols are often in the earlier to middle stages of chronic kidney disease, where the goal is to slow progression and improve overall quality of life. Always discuss these realities with your current healthcare provider, and avoid any facility that promises a cure or encourages you to abandon your prescribed dialysis routine. What Are the Potential Risks and Complications? Possible risks include infection at the administration site, mild immune reactions, unintended cellular behavior, and the possibility that the treatment may yield no clinical benefit. All medical procedures carry inherent risks, and investigational therapies are no exception. Common, mild side effects often include temporary fatigue, low-grade fever, or localized soreness if cells were administered via localized injection or if fat/bone marrow was extracted. More severe, albeit rare, risks include infections due to improper cell processing or administration techniques. Because the long-term behavior of cultured stem cells inside the human body is still being studied globally, there are theoretical risks regarding how the cells differentiate over time. The most common risk, financially and medically, is a lack of efficacy—spending time and money on a procedure that ultimately does not slow the progression of kidney disease. Who Might Be Considered for This Investigational Treatment? Suitable candidates often include adults with mild to moderate chronic kidney disease who have stable overall health and realistic expectations about investigational outcomes. Medical teams at international clinics evaluate patients on a case-by-case basis. While eligibility varies, a careful medical review is necessary before acceptance into a program. You may be considered if you meet criteria such as: Having a confirmed diagnosis of CKD, typically in stages 2 through 4. Maintaining stable blood pressure and blood sugar levels (especially if diabetic nephropathy is the underlying cause). Being free of active systemic infections or active cancers, as stem cells could theoretically promote tumor growth. Having a full understanding that the procedure is experimental. Possessing the ability to maintain regular follow-ups with a local physician upon returning home. Why Do Patients Travel for Medical Tourism in Mexico? Many patients travel because Mexico City offers access to emerging therapies at a lower financial threshold, often utilizing modern medical infrastructure and experienced bilingual professionals. The rise of medical tourism in Mexico is driven heavily by the accessibility of care. In the United States and Canada, stem cell therapies for kidney disease are strictly regulated and primarily confined to highly selective clinical trials. For patients who do not qualify for these trials, options at home are virtually non-existent. Mexico City hosts numerous private medical facilities equipped with advanced laboratories and specialists trained internationally. The cost of living and operational overhead in Mexico are lower, allowing clinics to offer these complex cell therapies at a fraction of what they might cost in other parts of the world. Additionally, the geographic proximity and abundance of direct flights make it a convenient destination for North American patients. What Should I Look for in a Stem Cell Therapy Clinic in Mexico City? Patients should prioritize clinics that hold local regulatory approvals, demonstrate transparent cell-handling protocols, employ specialized physicians, and prioritize honest medical communication. Selecting the right stem cell therapy clinic in Mexico City requires thorough vetting. Do not make decisions based solely on the lowest price tag or aggressive marketing claims. Look for facilities that are regulated by COFEPRIS (the Mexican federal authority for health risk protection). A legitimate clinic will be able to provide documentation of their licensing for cellular therapies. Furthermore, evaluate the medical staff. The procedure should ideally involve a multidisciplinary team, including a nephrologist who understands kidney pathophysiology, rather than just a general practitioner. A trustworthy clinic will require recent blood work, a thorough medical history, and will be upfront about the fact that they cannot guarantee a specific outcome. What Does the Recovery and Follow-Up Process Involve? While the immediate physical recovery is usually brief, long-term monitoring by a local healthcare provider is essential to track kidney function and safely manage your condition over time. The immediate recovery after the administration of stem cells is typically quite mild. Patients who receive intravenous infusions usually rest for a few hours at the clinic before returning to their hotel. If bone marrow or adipose tissue was harvested, you might experience bruising and soreness for a few days, requiring light activity and rest. However, the most vital part of the recovery process happens after you fly home. Stem cell therapy is not a "one-and-done" fix; it requires continuous monitoring. You must maintain your relationship with your local nephrologist. Regular blood tests (checking creatinine and BUN levels) and urine tests (monitoring protein levels) are necessary to evaluate if the therapy had any stabilizing effect and to ensure your kidney disease is not rapidly worsening. If you experience unexpected fevers, swelling, or severe pain after returning home, seek immediate medical attention locally. Why Choose PlacidWay for Medical Tourism in Mexico City? Planning international healthcare requires comprehensive research and careful coordination. PlacidWay serves as a global medical tourism platform designed to help patients discover and compare healthcare options around the world. Extensive Network: PlacidWay provides access to a large directory of medical facilities and specialty clinics in Mexico City and globally. Educational Resources: The platform offers articles, cost estimates, and informative guides to help patients understand various medical procedures. Direct Connections: Patients can use the platform to directly request information and initiate communication with international healthcare providers. Multilingual Platform: PlacidWay supports multiple languages, making it easier for diverse patients to navigate complex medical information. Treatment Comparisons: The system allows individuals to compare estimated prices, clinic profiles, and available treatments in different countries to find options that align with their needs. Frequently Asked Questions (FAQs) Is stem cell therapy for kidneys approved by the FDA? No, stem cell therapy for kidney failure is not currently approved by the FDA as a standard treatment. It remains an investigational procedure in the United States and globally, which is why some patients explore clinical trials or international medical tourism. How long do the effects of the treatment last? The duration of any potential benefits varies widely among patients. Some individuals report temporary improvements in symptoms that last for several months, while others may not experience any noticeable change. Ongoing monitoring is required. Do I need to stop my current kidney medications before treatment? You should never stop taking prescribed kidney medications without explicit instructions from your primary nephrologist. The treating clinic will review your medication list to determine if any temporary adjustments are necessary prior to the procedure. How are the stem cells administered? Stem cells are typically administered intravenously (IV) so they can circulate through the bloodstream, or in some specific protocols, they may be injected more directly into the targeted area using image guidance. Does the stem cell procedure hurt? The administration itself is usually well-tolerated. If cells are harvested from your own body (like bone marrow or fat), local anesthesia is used to minimize discomfort during the extraction process. IV infusions are generally painless. How soon can I travel back home after treatment? Most patients can return home within a few days of the procedure, provided they feel well and the treating physician has medically cleared them for travel. However, it is advisable to plan for a few days of rest in the city. Can international patients easily communicate with doctors in Mexico City? Yes, many private medical facilities in Mexico City that cater to international patients have bilingual staff and doctors who speak fluent English, making communication regarding medical history and treatment plans straightforward. What is the success rate of this treatment? Because it is an investigational therapy, there is no established universal success rate. Outcomes depend heavily on the severity of kidney disease, the patient's overall health, and how their unique biology responds to the therapy. Are donor cells screened for diseases? Reputable clinics strictly follow protocols to screen all donor (allogeneic) stem cells for infectious diseases, genetic abnormalities, and viability before they are used in any treatments. Will my health insurance cover this procedure in Mexico? No, standard health insurance plans generally do not cover experimental or investigational procedures, nor do they typically cover planned medical treatments performed internationally. Explore Your Medical Options Abroad Discover international clinics, compare estimated treatment costs, and request educational information about therapies worldwide. Request Treatment Information References FDA Warns About Stem Cell Therapies – U.S. Food and Drug Administration About Chronic Kidney Disease – National Kidney Foundation Mesenchymal Stem Cells for the Treatment of Kidney Disease – National Institutes of Health (PubMed) Frequently Asked Questions About Stem Cell Research – Mayo Clinic Medical Tourism: Travel for Medical Care – Centers for Disease Control and Prevention Patient Guide to Stem Cell Treatments – International Society for Stem Cell Research Medical Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute medical advice. Stem cell therapy for kidney failure is an investigational and experimental treatment and is not a guaranteed cure or replacement for standard medical treatments like dialysis or transplantation. Results vary significantly by patient. Always consult with a qualified, licensed healthcare professional, such as your primary nephrologist, before making any decisions regarding medical travel or experimental treatments.

The estimated stem cell therapy cost in Tijuana, Mexico for kidney conditions typically ranges from $5,000 to $10,000 per treatment session. Prices vary depending on the cell source, required dosage, and individual patient protocols. When facing the physical and emotional toll of chronic kidney disease (CKD), many patients look beyond conventional treatments to explore alternative options. In recent years, regenerative medicine has gained attention as an investigational approach for managing various chronic conditions. Seeking stem cell therapy for kidney failure in Tijuana, Mexico has become a notable consideration for international patients due to the proximity of the destination to the United States and the availability of advanced cellular protocols that may not yet be widely accessible elsewhere. However, it is crucial to approach this subject with realistic expectations. Stem cell therapy is not a cure for end-stage renal disease (ESRD), nor does it replace standard treatments such as dialysis or kidney transplantation. Instead, it is being studied for its potential to manage inflammation and possibly slow disease progression in carefully selected patients. Because the treatment is highly individualized, understanding the costs, medical implications, and safety requirements is essential before making any decisions. Key Takeaways The estimated cost for a full protocol generally falls between $5,000 and $10,000. Stem cell therapy for kidney conditions remains an investigational, alternative treatment. Treatment focuses on potentially reducing inflammation and slowing disease progression, not reversing end-stage kidney failure. Patients must undergo thorough medical screening to determine their eligibility. Consultation with a primary nephrologist is strictly recommended before pursuing medical tourism for regenerative therapies. How does stem cell therapy for kidney failure work? Stem cell therapy aims to utilize the body's natural healing mechanisms to reduce renal inflammation and support tissue repair, though it cannot regenerate a entirely new kidney. Mesenchymal stem cells (MSCs) are the most common type of cells used in these therapies. Rather than transforming into new kidney cells, research suggests that MSCs primarily work through a "paracrine effect." This means the cells release specific proteins, growth factors, and cytokines that communicate with the surrounding damaged tissues. The theoretical goal of this cellular communication is to modulate the immune system, decrease chronic inflammation, and stimulate the formation of new blood vessels (angiogenesis). In the context of chronic kidney disease, reducing systemic inflammation is vital because ongoing inflammation accelerates the deterioration of nephrons—the functional units of the kidneys. While clinical trials continue to investigate these mechanisms, results in human patients vary widely, and the treatment does not provide guaranteed outcomes. What is included in the stem cell therapy cost in Tijuana, Mexico? The quoted cost usually covers pre-treatment medical evaluations, the laboratory preparation of the cells, the clinical administration process, and basic immediate post-treatment observation. When you receive an estimate from a stem cell clinic in Tijuana, Mexico, it is important to ask for a detailed breakdown of what is included. Because regenerative medicine protocols are customized, no two treatment plans look exactly alike. Typically, a comprehensive package includes: Medical Consultations: Initial reviews of your kidney function tests (such as GFR and creatinine) by the clinic's medical team. Cell Sourcing and Expansion: The laboratory costs associated with acquiring, expanding, and testing the viability of the stem cells prior to infusion. Administration Fees: The clinical costs for administering the cells, which is usually done via an intravenous (IV) drip over several hours. Basic Follow-up: Immediate aftercare and observation while you are at the clinic to ensure you do not have an adverse reaction to the infusion. Travel expenses, accommodation, specialized localized imaging, and long-term remote follow-up consultations may incur additional fees. Always request a transparent, itemized quote before traveling. Are stem cell treatments for kidney disease medically approved? Stem cell therapy for chronic kidney disease is currently considered an investigational and alternative treatment, and it is not universally approved as a standard of care by major global health organizations. In many countries, including the United States, the Food and Drug Administration (FDA) has not approved stem cell products for the treatment of kidney failure. Conventional medicine relies on standardized treatments such as blood pressure management, dietary changes, dialysis, and kidney transplantation. Regenerative medicine is still undergoing rigorous clinical trials to establish standardized efficacy and long-term safety profiles. In Mexico, the regulatory body COFEPRIS oversees health facilities and the laboratories that process biological materials. While clinics may operate legally and follow strict laboratory safety protocols under Mexican law, this does not mean the therapy is universally recognized as a definitive cure. Patients must clearly understand that they are pursuing an alternative therapy and should discuss the implications extensively with their local healthcare provider. What types of stem cells are used for kidney conditions in Tijuana? Clinics typically utilize Mesenchymal Stem Cells (MSCs), which are most commonly sourced from ethically donated human umbilical cord tissue (Wharton's Jelly). The choice of stem cell type is a major factor in both the cost and the proposed protocol. There are two primary categories of stem cells used in these therapies: Allogeneic Cells (Donor-derived): These are usually Wharton's Jelly MSCs harvested from the umbilical cords of healthy, screened donors after a normal delivery. They are favored because they are young, robust, and generally have a low risk of triggering an immune rejection. Autologous Cells (Patient-derived): These cells are harvested from the patient's own body, typically from adipose (fat) tissue or bone marrow. However, in patients with chronic illness or advanced age, autologous cells may be less viable or effective compared to younger, donor-derived cells. Most modern clinics focusing on systemic conditions like chronic kidney disease prefer umbilical cord-derived MSCs because they can be expanded in a laboratory to yield the high cell counts often required for therapeutic protocols. Who might be a suitable candidate for this treatment? Suitable candidates are often those in the earlier or middle stages of chronic kidney disease (Stages 2 to 4) who are looking to slow the progression of their condition. Not everyone is an ideal candidate for regenerative therapies. A responsible medical team will conduct a thorough screening process before accepting a patient. Generally, individuals who retain some degree of viable kidney function may be considered better candidates because the therapy relies on supporting remaining healthy tissue. Patients with Stage 5 chronic kidney disease (end-stage renal disease) who require continuous dialysis usually have extensive, irreversible scarring (fibrosis) in the kidneys. While some clinics may still offer treatments to these patients with the aim of improving general quality of life or managing systemic symptoms, it is medically unlikely that stem cells will reverse the need for dialysis at this stage. Additionally, individuals with active infections, a history of certain cancers, or severe cardiovascular instability are typically contraindicated for this treatment. What are the potential risks and side effects? While minimally invasive, potential risks include injection site reactions, transient fever, fatigue, infection, and the unknown long-term effects of introducing biological materials into the body. Patient safety must always be the top priority. Mesenchymal stem cells are generally considered to have a strong safety profile regarding acute immune rejection (they are immunoprivileged), but no medical procedure is entirely without risk. Following an intravenous infusion, some patients experience mild, short-term side effects such as a low-grade fever, headache, nausea, or fatigue as the body processes the new cells. More severe risks, though less common, include bacterial infection (if the cells were improperly screened or handled) or an unexpected immune response. Because long-term data on large populations receiving these treatments is still being collected, the potential for unforeseen future complications cannot be completely ruled out. It is imperative to choose facilities that adhere strictly to stringent laboratory standards and cell viability testing. How many treatment sessions are typically required? Most initial protocols involve one comprehensive treatment course administered over a period of 1 to 3 days, though some patients may opt for follow-up sessions months or years later. The number of cells required—and consequently the number of infusion sessions—depends entirely on the patient's weight, overall health, and the severity of the kidney condition. A standard protocol might involve the intravenous administration of tens of millions to over a hundred million MSCs. To prevent overwhelming the body and to maximize absorption, this high dosage is frequently divided into smaller infusions administered over consecutive days. After the initial therapy course is completed, the medical team will monitor the patient's blood work remotely over the following months. Based on the patient's response and disease trajectory, some individuals may choose to return for "booster" treatments, though this incurs additional costs. How long does it take to recover and see potential results? Immediate physical recovery from the infusion usually takes only a few days, but any potential systemic improvements in kidney function metrics may take 3 to 6 months to evaluate. The procedure itself is typically performed on an outpatient basis. Most patients feel well enough to return to their normal daily activities within 24 to 48 hours after their final infusion. However, it is advised to avoid strenuous physical exertion and strictly adhere to any prescribed dietary guidelines during the initial post-treatment phase. Assessing the efficacy of the treatment is a waiting game. Stem cells do not provide an overnight fix; the biological processes of modulating inflammation and supporting tissue repair occur gradually. Patients are typically instructed to have their local doctor run standard renal function panels (monitoring eGFR, creatinine, and BUN levels) at 1-month, 3-month, and 6-month intervals. Outcomes are highly variable; while some patients report stabilization of their numbers and improved energy levels, others may experience no measurable clinical benefit. Why do patients travel for medical tourism in Tijuana, Mexico? Patients often engage in medical tourism in Tijuana, Mexico due to the accessibility of specialized stem cell protocols, geographical convenience, and potentially lower treatment costs compared to domestic options. Tijuana has positioned itself as a major global hub for medical tourism, attracting thousands of international patients annually. For individuals seeking alternative therapies for chronic conditions, the primary driver is often access. Regulatory frameworks in Mexico allow specialized clinics to culture and administer expanded stem cells in quantities that are heavily restricted in places like the United States and Canada. Furthermore, Tijuana's location just across the border from San Diego, California, makes it highly accessible for North American patients. Many established clinics offer seamless logistical support, including private border transfers from San Diego airports directly to their facilities. While the cost is a significant factor—often presenting savings compared to similar experimental treatments elsewhere—patients must weigh these financial benefits against the inherent uncertainties of pursuing alternative medicine abroad. What should patients ask a stem cell clinic before booking? Patients must proactively verify the clinic's regulatory compliance, the credentials of the medical staff, the source of the biological materials, and the comprehensiveness of their patient screening processes. Thorough due diligence is non-negotiable when planning international medical care, especially for complex conditions like kidney failure. Before committing to any treatment plan, consider asking the following critical questions: Are your facility and your partner laboratory fully licensed and certified by COFEPRIS? Who is the attending physician, and what is their specific experience with cellular therapies and chronic conditions? Can you provide a Certificate of Analysis (CoA) demonstrating the viability, cell count, and sterility of the stem cells you intend to use? What criteria do you use to determine if I am a safe and viable candidate for this procedure? What specific emergency protocols do you have in place in the event of an adverse reaction during treatment? Why Choose PlacidWay for Medical Tourism? Navigating international healthcare options can be overwhelming. PlacidWay serves as an educational and informational resource designed to assist patients in exploring medical facilities worldwide. Here is what PlacidWay provides: Extensive Network: Access to a wide database of international medical centers and specialized clinics. Comparative Information: The ability to review and compare estimated costs, facility details, and treatment protocols in one place. Educational Resources: Informative guides that help patients understand the logistics and considerations of seeking care abroad. Direct Communication: Tools that allow you to request information directly from healthcare providers. No Hidden Platform Fees: PlacidWay offers its informational platform to patients without charging hidden booking fees. Frequently Asked Questions Is stem cell therapy a cure for end-stage kidney failure? No, stem cell therapy is not a cure for end-stage renal disease (ESRD). It is an investigational treatment that may help manage inflammation and potentially slow disease progression in earlier stages, but it does not replace the need for dialysis or a kidney transplant. Does health insurance cover stem cell treatments in Tijuana? Health insurance providers generally do not cover stem cell therapy for kidney disease, whether performed domestically or internationally, because the treatment is classified as experimental or investigational. Can I stop dialysis after receiving stem cells? You should never stop dialysis or any prescribed medical treatment without explicit instructions from your primary nephrologist. Stem cell therapy is not a recognized replacement for dialysis. How long do I need to stay in Tijuana for treatment? Most patients stay in Tijuana for 2 to 5 days. This allows time for an initial medical consultation, the administration of the stem cells (which often takes just a few hours), and a brief observation period before traveling home. Are stem cell treatments painful? The treatment is typically minimally invasive. If the cells are administered intravenously (IV), you will experience a standard needle prick similar to a blood draw. Mild discomfort may occur depending on the specific administration route. What medical records do I need to provide? You will need to provide recent comprehensive blood panels, a detailed medical history, current kidney function tests (such as eGFR and creatinine levels), imaging results, and a list of all current medications. Can I travel back home immediately after treatment? While many patients travel home the day after their final infusion, it is recommended to rest and follow the clinic's specific post-treatment travel guidelines to ensure proper recovery and monitor for any immediate adverse reactions. How do I know if the cells are ethically sourced? Reputable clinics use cells that are processed in specialized laboratories regulated by COFEPRIS (Mexico's health regulatory agency). You should always ask the clinic for documentation regarding their cell sourcing, laboratory certifications, and viability testing. What happens if I experience complications after returning home? Before traveling, you should establish a plan with your local healthcare provider for post-treatment care. If complications arise, you should seek immediate medical attention from your local hospital or nephrologist. How do Mexican clinics regulate stem cell safety? Legitimate clinics and their partner laboratories operate under the strict oversight of COFEPRIS, which sets safety, hygiene, and ethical standards for medical facilities and biological products in Mexico. Explore Your Treatment Options Gather the information you need to make an educated decision about your healthcare journey. Request educational materials and facility details today. Request Treatment Information Medical Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute medical advice. Stem cell therapy for chronic kidney disease is an investigational and alternative treatment. Results, eligibility, and potential risks vary by individual. Always consult with a licensed, qualified nephrologist or primary care physician before making any decisions regarding medical treatments or traveling abroad for healthcare. References Kidney Disease Information – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) About Chronic Kidney Disease – National Kidney Foundation Patient Resources on Stem Cell Therapies – International Society for Stem Cell Research (ISSCR) Important Patient Information About Regenerative Medicine – U.S. Food and Drug Administration (FDA) Clinical Studies on Mesenchymal Stem Cells and Renal Function – National Library of Medicine (PubMed) Medical Tourism Safety and Guidelines – Centers for Disease Control and Prevention (CDC) Health and Sanitation Regulations – Federal Commission for the Protection against Sanitary Risk (COFEPRIS, Mexico)